Reduction in Peripheral CD19+ CD27- Naive B Cells Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis Receiving Combined Treatment with Methotrexate and TNF Inhibitors

被引：0

作者：

Hernandez-Breijo, Borja ^{[1
]}

Plasencia, Chamaida ^{[2
]}

Navarro-Compan, Victoria ^{[3
]}

Nieto-Ganan, Israel ^{[4
]}

Sobrino, Cristina ^{[5
]}

Martinez-Feito, Ana ^{[3
]}

Garcia-Hoz, Carlota ^{[4
]}

Lapuente-Suanzes, Paloma ^{[4
]}

Bachiller-Corral, Javier ^{[6
]}

Bonilla, Gema ^{[2
]}

Pijoan-Moratalla, Cristina ^{[6
]}

Roy, Garbine ^{[4
]}

Vazquez, Monica ^{[6
]}

Balsa, Alejandro ^{[2
]}

Villar, Luisa M. ^{[4
]}

Pascual-Salcedo, Dora ^{[3
]}

Rodriguez-Martin, Eulalia ^{[4
]}

机构：

[1] La Paz Univ Hosp, IdiPAZ, Immunorheumatol Res Grp, Madrid, Spain

[2] La Paz Univ Hosp, IdiPAZ, Rheumatol, Madrid, Spain

[3] Hosp Univ La Paz, IdiPaz, Madrid, Pais Vasco, Spain

[4] Hosp Univ Ramon & Cajal, IRYCIS, Madrid, Spain

[5] Hosp Ramon & Cajal, IRYCIS, Madrid, Spain

[6] Hosp Univ Ramon & Cajal, Rheumatol, Madrid, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1227

引用

页数：3

共 26 条

[21] Peripheral blood CD4+ CD25+ CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response
Kikuchi, Jun
Hashizume, Misato
Kaneko, Yuko
Yoshimoto, Keiko
Nishina, Naoshi
Takeuchi, Tsutomu
ARTHRITIS RESEARCH & THERAPY, 2015, 17
[22] B Cells Identified According to Their Expression of CD19 and Surface Ig Are Depleted From Peripheral Blood by Rituximab in Patients With Rheumatoid Arthritis: Comment on the Article by Jones et al
Mei, Henrik E.
Doerner, Thomas
ARTHRITIS AND RHEUMATISM, 2013, 65 (04): : 1132 - 1132
[23] Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1)
SchulzeKoops, H
Lipsky, PE
Kavanaugh, AF
Davis, LS
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (02): : 190 - 196
[24] CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment
Koji, Hitoshi
Yazawa, Takuya
Nakabayashi, Kimimasa
Fujioka, Yasunori
Kamma, Hiroshi
Yamada, Akira
MODERN RHEUMATOLOGY, 2016, 26 (02) : 271 - 275
[25] Expansion of T cells expressing inhibitory receptor CD94/NKG2A in patients with rheumatoid arthritis in clinical remission following treatment with anti-tumour necrosis factor-alpha agents.
Walsh, CA
O'Farrelly, C
Golden-Mason, L
Veale, DJ
FitGerald, O
Bresnihan, B
Fearon, U
ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4071 - 4071
[26] Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti-CD19-chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B-cell lymphoma and high tumor burden
Mu, Juan
Deng, Haobin
Lyu, Cuicui
Yuan, Jijun
Li, Qing
Wang, Jia
Jiang, Yanyu
Deng, Qi
Shen, Jichun
HEMATOLOGICAL ONCOLOGY, 2023, 41 (02) : 275 - 284

← 1 2 3 →